Provided by Tiger Fintech (Singapore) Pte. Ltd.

C4 Therapeutics, Inc.

2.56
+0.05001.99%
Post-market: 2.590.0300+1.17%18:48 EDT
Volume:1.13M
Turnover:2.95M
Market Cap:182.20M
PE:-1.62
High:2.72
Open:2.50
Low:2.50
Close:2.51
52wk High:7.22
52wk Low:1.09
Shares:71.17M
Float Shares:50.03M
Volume Ratio:1.40
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5822
EPS(LYR):-1.5181
ROE:-52.99%
ROA:-22.80%
PB:1.05
PE(LYR):-1.69

Loading ...

Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence